• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗后的心绞痛:支架内再狭窄。

Angina following percutaneous coronary intervention: in-stent restenosis.

作者信息

Throndson Karen, Sawatzky Jo-Ann V

机构信息

Faculty of Nursing, University of Manitoba.

出版信息

Can J Cardiovasc Nurs. 2009;19(3):16-23.

PMID:19694113
Abstract

Percutaneous coronary intervention (PCI) represents a technical advance in the treatment of coronary artery disease. However, it is not without risks both during and after the procedure. In-stent restenosis (ISR) is the most common complication following PCI. Individuals who experience angina associated with ISR often fail to recognize its seriousness and, therefore, do not respond appropriately to the situation. Individuals with ISR are vulnerable to the consequences of angina, including increased morbidity and mortality, as well as a decreased health-related quality of life. In this article, the authors review the risks for developing ISR, the pathophysiology of angina related to ISR, and the challenges that face patients who develop recurrent angina post-PCI. Cardiovascular nurses play a critical role in the clinical management and education of patients following PCI. The provision of post-PCI follow-up care is key to identifying, managing, and supporting patients with recurrent angina.

摘要

经皮冠状动脉介入治疗(PCI)是冠状动脉疾病治疗领域的一项技术进步。然而,该手术过程中和术后并非没有风险。支架内再狭窄(ISR)是PCI术后最常见的并发症。经历与ISR相关心绞痛的患者往往意识不到其严重性,因此对这种情况反应不当。患有ISR的个体易受心绞痛后果的影响,包括发病率和死亡率增加,以及健康相关生活质量下降。在本文中,作者回顾了发生ISR的风险、与ISR相关心绞痛的病理生理学,以及PCI术后发生复发性心绞痛患者所面临的挑战。心血管护士在PCI术后患者的临床管理和教育中起着关键作用。提供PCI术后随访护理是识别、管理和支持复发性心绞痛患者的关键。

相似文献

1
Angina following percutaneous coronary intervention: in-stent restenosis.经皮冠状动脉介入治疗后的心绞痛:支架内再狭窄。
Can J Cardiovasc Nurs. 2009;19(3):16-23.
2
Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.经皮冠状动脉介入治疗会引发支架内再狭窄患者的全身炎症反应——与稳定型和不稳定型心绞痛的比较。
Inflamm Res. 2005 May;54(5):187-93. doi: 10.1007/s00011-005-1342-0.
3
Bare metal stent restenosis is not a benign clinical entity.裸金属支架再狭窄并非一种良性临床情况。
Am Heart J. 2006 Jun;151(6):1260-4. doi: 10.1016/j.ahj.2005.08.011.
4
Analysis of clinical factors affecting the restenosis following percutaneous coronary intervention.经皮冠状动脉介入治疗后影响再狭窄的临床因素分析。
Nepal Med Coll J. 2005 Dec;7(2):101-6.
5
Rescue left main angioplasty on first post-operative day of coronary artery bypass graft surgery ischemia.
J Invasive Cardiol. 1999 Nov;11(11):688-90.
6
Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase.接受冠状动脉支架置入术的患者循环脂联素基础水平较低可预测支架内再狭窄,且独立于炎症标志物——脂蛋白相关磷脂酶A2和髓过氧化物酶的基础水平。
Clin Biochem. 2008 Dec;41(18):1429-33. doi: 10.1016/j.clinbiochem.2008.09.109. Epub 2008 Oct 7.
7
Recurrent angina after coronary revascularization: a clinical challenge.冠状动脉血运重建术后复发性心绞痛:一项临床挑战。
Eur Heart J. 2007 May;28(9):1057-65. doi: 10.1093/eurheartj/ehl562. Epub 2007 Mar 23.
8
Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris.血小板衍生趋化因子RANTES可能是稳定型心绞痛患者经皮冠状动脉介入治疗后再狭窄的一个迹象。
Platelets. 2006 Dec;17(8):565-70. doi: 10.1080/09537100600759618.
9
Alpha particle vascular brachytherapy in the treatment of in-stent Restenosis.α粒子血管内近距离放射治疗支架内再狭窄
Int J Cardiol. 2009 Aug 14;136(2):220-1. doi: 10.1016/j.ijcard.2008.04.036. Epub 2008 Jul 14.
10
Treatment of patients with in-stent restenosis.支架内再狭窄患者的治疗。
EuroIntervention. 2009 May;5 Suppl D:D70-8.

引用本文的文献

1
The association between stent type and developing angina pectoris following percutaneous coronary intervention.支架类型与经皮冠状动脉介入治疗后心绞痛发展的关系。
BMC Cardiovasc Disord. 2024 Sep 2;24(1):466. doi: 10.1186/s12872-024-04116-2.
2
Mechanical analysis of a novel biodegradable zinc alloy stent based on a degradation model.基于降解模型的新型可降解锌合金支架的机械分析。
Biomed Eng Online. 2019 Apr 2;18(1):39. doi: 10.1186/s12938-019-0661-2.
3
Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention.
胱抑素C和超敏C反应蛋白在接受经皮冠状动脉介入治疗的冠心病患者中的临床意义
Braz J Cardiovasc Surg. 2019 Jan-Feb;34(1):17-21. doi: 10.21470/1678-9741-2018-0171.
4
Mediating effect of illness perception on the relationship between Type D personality and health behaviors among coronary artery disease patients.疾病认知在冠心病患者D型人格与健康行为关系中的中介作用。
Health Psychol Open. 2018 Dec 12;5(2):2055102918817228. doi: 10.1177/2055102918817228. eCollection 2018 Jul-Dec.
5
Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey.冠心病和复发性心绞痛样胸痛患者用奥美拉唑治疗后的健康相关生活质量改善。SF-36 调查的双盲、安慰剂对照试验。
Health Qual Life Outcomes. 2011 Sep 22;9:77. doi: 10.1186/1477-7525-9-77.